ArcticZymes Technologies — Investor Presentation 2021

Sep 1, 2021

ArcticZymes Technologies

Shaped by the Arctic

September 2021

Specialist supplier of best-in-class novel enzymes

Innovative Offering

B2B and OEM sales

Performance

• Novel enzymes technology
• Focus on high-quality, robust manufacturing and reliable supply
• Broad customer base and longterm commercial relationships

• Serve 3 attractive growth market

• Profitable & sales rapidly growing

• Forward leaning growth strategy

Our Novel Enzyme Products

Focus on enzymes that manipulate DNA, for example:

Therapeutics

• Cell & gene therapy
• Viral vaccines

Salt Active Nuclease

• Cuts and destroys DNA/RNA
• Novel feature active in high salt

Solves Main Challenge

• Optimal to purify virus in a high salt environment

Benefits

• Optimal solution
• Streamlines workflow
• Cost effective

Innovations and Molecular Enzyme Market

Estimated value \$1.2 Bil (2021) - therapeutic utility will accelerate growth

Target Markets & Customers

[Source: internal data and various marketing reports]

Serving attractive & growing markets

Our Customers

ArcticZymes is a trusted critical raw material supply

Our Business Dynamics

• Large volume bulk sales (often >1MNOK orders)
• Economies of scale achieve highest gross margins
• Enzymes are integrated into our customers products or manufacturing processes (long-term business created)

Financial Performance

Annual Growth and Profitable

Sales contribution (2021)

Therapeutics	Research	Diagnostics
30 %	23 %	47 %

Quarterly sales and EBITDA margins

Growth Strategy

European's leading one-stop-shop novel enzyme supplier

Simplified Workflow (Molecular Diagnostics)

• Value chain (Workflow)
• Achieved through building a complete portfolio of enzymes to support any workflow and technology
• Adopting a forward leaning approach via organic and inorganic growth initiatives (M&A and in-licensing)
• Extend activities into therapeutics there is a greater market potential

Value chain (Technology)

Summary

High Growth Business

About leverage existing and new long-term B2B relationships

Accelerate Expansion

Build Long-Term Shareholder Value

Broaden product range:

• Bolt and build via M&A
• Ramp up innovation pipeline & operations

Driven by sustainable profitablity and topline growth

Thank you

Q&A Session

Disclaimer

This presentation contains certain forward-looking information and statements. Such forward-looking information and statements are based on the current, estimates and projections of the Company or assumptions based on information currently available to the Company. Such forward-looking information and statements reflect current views with respect to future events and are subject to risks, uncertainties and assumptions. The Company cannot give assurance to the correctness of such information and statements. These forward-looking information and statements can generally be identified by the fact that they do not relate only to historical or current facts.

Forward-looking statements sometimes use terminology such as "targets", "believes", "expects", "aims", "assumes", "intends", "plans", "seeks", "will", "may", "anticipates", "would", "could", "continues", "estimate", "milestone or other words of similar meaning and similar expressions or the negatives thereof. By their nature, forward-looking information and statements involve known and unknown risks, uncertainties and other important factors that could cause the actual results, performance or achievements of the Company to differ materially from any future results, performance or achievements that may be expressed or implied by the forward-looking information and statements in this presentation. Should one or more of these risks or uncertainties materialize, or should any underlying assumptions prove to be incorrect, the Company's actual financial condition or results of operations could differ materially from that or those described herein as anticipated, believed, estimated or expected.

Any forward-looking information or statements in this presentation speak only as at the date of this presentation. Except as required by the Oslo Stock Exchange rules or applicable law, the Company does not intend, and expressly disclaims any obligation or undertaking, to publicly update, correct or revise any of the information included in this presentation, including forward-looking information and statements, whether to reflect changes in the Company's expectations with regard thereto or as a result of new information, future events, changes in conditions or circumstances or otherwise on which any statement in this presentation is based. Given the aforementioned uncertainties, prospective investors are cautioned not to place undue reliance on any of these forwardlooking statements.